The ERMI Score: Why Environmental Professionals Don't Recommend It (And You Shouldn't Either)

Few topics generate more confusion — and more unnecessary remediation spending — in the indoor environmental quality field than the Environmental Relative Moldiness Index, commonly known as ERMI. Marketed by commercial labs as a cutting-edge DNA-based mold assessment tool, and enthusiastically recommended by a subset of integrative medicine practitioners, the ERMI has become deeply entrenched in mold-illness communities. The problem is that the evidence supporting its use as a clinical or remediation decision-making tool remains, to put it plainly, absent.

What ERMI Is — And What It Was Never Designed to Do

ERMI was developed by the U.S. Environmental Protection Agency and the U.S. Department of Housing and Urban Development. Its original purpose was research-focused: to investigate how indoor mold exposure in children's environments, primarily low-income housing, contributed to the development of asthma.

This distinction matters enormously. The EPA itself has stated clearly that ERMI is a research tool and is not recommended for use except as a research tool. That position hasn't changed. The EPA Inspector General further reinforced that ERMI has not been peer-reviewed for consumer use and warned of the risk of misinterpretation leading to unnecessary or excessive remediation.

Despite this, the test is now routinely marketed to homeowners as a definitive assessment of their indoor environment — a use case it was never designed for, and one its creators explicitly caution against.

Problem #1: The Scoring Formula Is Fundamentally Flawed

The ERMI score is calculated by measuring DNA from 36 mold species in settled dust, grouping 26 as "water-damage associated" (Group 1) and 10 as "outdoor" species (Group 2), then subtracting the Group 2 log sum from the Group 1 log sum. On the surface, this sounds rigorous. In practice, the formula introduces systematic error that undermines its reliability as a diagnostic tool.

The formula groups mold spores into those that typically grow outdoors and those often associated with water damage — but this is an impossible distinction to make cleanly. Cladosporium, for example, is one of the most common mold types found with indoor water damage, yet the ERMI formula places it as an outdoor mold spore. Therefore, if a home had high levels of Cladosporium growing indoors, those counts would actually be subtracted from the data, and the home could receive a clean bill of health.

The mathematical consequences of this can be counterintuitive. If a home had six Group 1 (bad) molds and eight Group 2 (good) molds, the ERMI score would be -2 — suggesting low risk. After thorough remediation that removed most of the mold, a follow-up test might yield three Group 1 molds and zero Group 2 molds, producing an ERMI score of +3 — suggesting the environment worsened. The mold burden decreased, but the score went up. This is not a minor edge case; it is a structural problem with the formula itself.

Additionally, ERMI test results are still compared to dust samples collected in 2005, using a scale that hasn't been updated in nearly 20 years. Building practices, materials, HVAC system designs, and regional fungal ecology have all shifted substantially in that time. Comparing a modern Wisconsin home to a 2005 national reference dataset of 1,096 homes introduces unquantifiable geographic and temporal confounding.

Problem #2: Settled Dust Is Not a Measure of Current Exposure

One of the most significant misapplications of ERMI is its use to evaluate current occupant health risk. ERMI testing uses settled dust as the sample material — which doesn't tell us anything about current conditions. Unlike air sampling, which captures what occupants are actively inhaling at a defined point in time, settled dust integrates an unknown accumulation period.

Consider a home where there were no mold problems for the past two months, but a three-day period three months prior when many mold spores were released when the homeowner opened a moldy tent inside the home to dry it out. The elevated mold spores were not part of an ongoing mold issue, but they would still show up in the ERMI sample.

The DNA signatures in dust samples may reflect mold events from months or even years ago. In homes where carpets haven't been cleaned or replaced, this historic contamination can dominate ERMI results, suggesting current mold issues where there are none.

Furthermore, because ERMI quantifies spore equivalents per milligram of dust — not per cubic meter of air — it doesn't directly correlate with actual occupant exposure. Traditional spore trap air sampling yields spores per cubic meter, which is far more useful for evaluating health risk and remediation needs.

Problem #3: The Sampling Methodology Is Not Reproducible

Scientific validity requires that a test produce consistent results when applied consistently. ERMI does not meet this standard.

Air sampling achieves reproducibility because the sampling volume is precisely controlled: a known volume of air is drawn through a collection medium at a calibrated flow rate, yielding results expressed per cubic meter. The ERMI test is quite different. The amount of sampling may be highly variable. With the Swiffer-style sampling technique used to collect dust, it is extremely difficult to quantify the sample. Therefore, comparing different tests is near impossible.

Variables such as wiping pressure, surface area covered, and surface texture — high-gloss trim paint versus matte finish, carpet versus hardwood — all yield fundamentally different dust loads, with no way to normalize across them. Without a standardized, quantifiable collection volume, the results from one test cannot be meaningfully compared to a prior test in the same building, let alone to a national reference database.

This is not a theoretical concern. A PMC-published study comparing vacuum and electrostatic cloth sampling methods found that while average Group 1 and Group 2 mold concentrations were correlated across methods, 35% of samples proved to be false positives when the electrostatic cloth method was used at the same ERMI cutoff value as the vacuum method. A false positive rate of one in three is disqualifying for a test routinely used to justify five- and six-figure remediation projects.

Problem #4: Commercial Exploitation Has Outpaced the Science

ERMI's popularity is largely attributable to Ritchie Shoemaker, a controversial physician who developed the Shoemaker Protocol to address Chronic Inflammatory Response Syndrome (CIRS), a condition he coined that is associated with biotoxin exposure. Shoemaker incorporated ERMI — and a derivative panel he created called HERTSMI-2 — into his clinical protocol. As the protocol gained followers, physicians began recommending ERMI to patients while amplifying its perceived benefits. It has long been alleged that Shoemaker holds an ownership interest in the specific lab he aggressively promotes — a claim he denies.

The commercial ecosystem that has grown around ERMI creates significant conflicts of interest. Labs selling ERMI kits directly to consumers or to physicians benefit financially from elevated test volumes, regardless of whether those tests produce actionable or valid results. Some companies falsely market ERMI as EPA-approved, and some medical professionals mistakenly treat it as a test panel for detecting toxin-producing molds — which it is not.

ERMI identifies fungal DNA. It does not measure mycotoxin concentrations. It does not confirm active growth. It does not assess current airborne exposure. These are not subtle limitations — they are fundamental mismatches between what the test measures and how it is being clinically applied.

What Should Be Done Instead

A properly scoped indoor environmental investigation does not rely on a single number derived from an unstandardized dust swipe. It integrates:

• Calibrated air sampling (spore trap or qPCR-based) that captures current airborne conditions in defined cubic-meter volumes

• Targeted surface sampling (tape lift or bulk) from areas of visual concern or moisture intrusion

• Moisture mapping with calibrated pin/pinless meters and thermal imaging to locate active or historical wetting

• Building forensics — vapor drive analysis, ventilation assessment, and material history — that contextualizes any biological findings

ERMI may have a narrow role as one data point in a comprehensive forensic investigation, particularly for retrospective documentation of water-damage history in a litigation or property-disclosure context. But it is not, and has never been, a stand-alone diagnostic tool. Using it as such — or allowing a lab report to drive a remediation scope — is an error that costs homeowners money, generates unnecessary anxiety, and in some cases results in work that doesn't address the actual problem.

The EPA created ERMI. The EPA does not recommend its use outside of research. That should be the beginning and the end of this conversation for any competent indoor environmental professional.

This post reflects the professional opinion of MD Mold | Environmental Consulting based on a review of peer-reviewed literature and EPA guidance. References available upon request.